Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 Vascular endothelial growth factor (VEGF)-165 induces neovascularization in the infarct zone. Representative sections of the infarct zone four weeks after injection into the peri-infarct zone of either 1 million skeletal myoblasts (SKMB) transfected with AdLuciferase (A, D), 1 x 107 pfu adenoviral VEGF-165 (AdVEGF-165) (B, E), or 1 million SKMB transfected with AdVEGF-165 (C, F) in five equally divided injections. (A, B, C) H & E staining and (D, E, F) immunohistochemistry for von Willebrand factor.
|
